1. Home
  2. APYX vs MDXH Comparison

APYX vs MDXH Comparison

Compare APYX & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.68

Market Cap

128.0M

Sector

Health Care

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$2.25

Market Cap

149.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
MDXH
Founded
1982
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.0M
149.0M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
APYX
MDXH
Price
$3.68
$2.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$6.50
$7.67
AVG Volume (30 Days)
123.2K
162.7K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
19.40
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.92
$30.78
Revenue Next Year
$10.08
$18.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.83
$1.36
52 Week High
$4.50
$5.33

Technical Indicators

Market Signals
Indicator
APYX
MDXH
Relative Strength Index (RSI) 49.59 18.14
Support Level $3.27 $1.90
Resistance Level $4.29 $2.30
Average True Range (ATR) 0.26 0.21
MACD 0.00 -0.10
Stochastic Oscillator 37.35 1.13

Price Performance

Historical Comparison
APYX
MDXH

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: